248 related articles for article (PubMed ID: 35590395)
1. The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis.
Greenham L; Bennett PN; Dansie K; Viecelli AK; Jesudason S; Mister R; Smyth B; Westall P; Herzog S; Brown C; Handke W; Palmer SC; Caskey FJ; Couchoud C; Simes J; McDonald SP; Morton RL
Trials; 2022 May; 23(1):419. PubMed ID: 35590395
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial.
Agarwal N; Shah KK; Dansie K; Bennett PN; Greenham L; Brown C; Smyth B; McDonald S; Jesudason S; Viecelli AK; Morton RL;
BMC Nephrol; 2023 Nov; 24(1):345. PubMed ID: 37993776
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and acceptability of e-PROMs data capture and feedback among patients receiving haemodialysis in the Symptom monitoring WIth Feedback Trial (SWIFT) pilot: protocol for a qualitative study in Australia.
Duncanson E; Bennett PN; Viecelli A; Dansie K; Handke W; Tong A; Palmer S; Jesudason S; McDonald SP; Morton RL;
BMJ Open; 2020 Nov; 10(11):e039014. PubMed ID: 33158824
[TBL] [Abstract][Full Text] [Related]
4. Use of patient-reported outcome measures and patient-reported experience measures in renal units in Australia and New Zealand: A cross-sectional survey study.
Morton RL; Lioufas N; Dansie K; Palmer SC; Jose MD; Raj R; Salmon A; Sypek M; Tong A; Ludlow M; Boudville N; McDonald S
Nephrology (Carlton); 2020 Jan; 25(1):14-21. PubMed ID: 30838732
[TBL] [Abstract][Full Text] [Related]
5. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
[TBL] [Abstract][Full Text] [Related]
6. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
Trials; 2020 May; 21(1):428. PubMed ID: 32450917
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial.
Logan B; Viecelli AK; Johnson DW; Aquino EM; Bailey J; Comans TA; Gray LC; Hawley CM; Hickey LE; Janda M; Jaure A; Jose MD; Kalaw E; Kiriwandeniya C; Matsuyama M; Mihala G; Nguyen KH; Pascoe E; Pole JD; Polkinghorne KR; Pond D; Raj R; Reidlinger DM; Scholes-Robertson N; Varghese J; Wong G; Hubbard RE;
Trials; 2023 May; 24(1):365. PubMed ID: 37254217
[TBL] [Abstract][Full Text] [Related]
8. Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol.
Chow JSF; Boudville N; Cho Y; Palmer S; Pascoe EM; Hawley CM; Reidlinger DM; Hickey LE; Stastny R; Valks A; Vergara L; Movva R; Kiriwandeniya C; Candler H; Mihala G; Buisman B; Equinox KL; Figueiredo AE; Fuge T; Howard K; Howell M; Jaure A; Jose MD; Lee A; Miguel SS; Moodie JA; Nguyen TT; Pinlac G; Reynolds A; Saweirs WWM; Steiner-Lim GZ; TeWhare B; Tomlins M; Upjohn M; Voss D; Walker RC; Wilson J; Johnson DW
Trials; 2023 Nov; 24(1):730. PubMed ID: 37964367
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of Cooled HaEmodialysis on Cognitive function in patients suffering with end-stage KidnEy Disease (E-CHECKED): feasibility randomised control trial protocol.
Dasgupta I; Odudu A; Baharani J; Fergusson N; Griffiths H; Harrison J; Maruff P; Thomas GN; Woodhall G; Youseff S; Tadros G
Trials; 2020 Sep; 21(1):820. PubMed ID: 32998761
[TBL] [Abstract][Full Text] [Related]
10. A cluster randomized controlled trial for the Evaluation of routinely Measured PATient reported outcomes in HemodialYsis care (EMPATHY): a study protocol.
Johnson JA; Al Sayah F; Buzinski R; Corradetti B; Davison SN; Elliott MJ; Klarenbach S; Manns B; Schick-Makaroff K; Short H; Thomas C; Walsh M
BMC Health Serv Res; 2020 Aug; 20(1):731. PubMed ID: 32778102
[TBL] [Abstract][Full Text] [Related]
11. Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial.
Luckett T; Phillips J; Agar M; Lam L; Davidson PM; McCaffrey N; Boyle F; Shaw T; Currow DC; Read A; Hosie A; Lovell M
BMC Health Serv Res; 2018 Jul; 18(1):558. PubMed ID: 30012122
[TBL] [Abstract][Full Text] [Related]
12. The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial.
Hull KL; Bramham K; Brookes CL; Cluley V; Conefrey C; Cooper NJ; Eborall H; Fotheringham J; Graham-Brown MPM; Gray LJ; Mark PB; Mitra S; Murphy GJ; Quann N; Rooshenas L; Warren M; Burton JO
Trials; 2023 Aug; 24(1):522. PubMed ID: 37573352
[TBL] [Abstract][Full Text] [Related]
13. A bundled phosphate control intervention (4Ds) for adults with end-stage kidney disease receiving haemodialysis: A cluster randomized controlled trial protocol.
Milazi M; Douglas C; Bonner A
J Adv Nurs; 2018 Oct; 74(10):2431-2441. PubMed ID: 29943430
[TBL] [Abstract][Full Text] [Related]
14. Self-reported MeasUrement of Physical and PsychosOcial Symptoms Response Tool (SUPPORT-dialysis): systematic symptom assessment and management in patients on in-centre haemodialysis - a parallel arm, non-randomised feasibility pilot study protocol.
Gill JK; Pucci M; Samudio A; Ahmed T; Siddiqui R; Edwards N; Marticorena RM; Donnelly S; Lok C; Wentlandt K; Wolofsky K; Mucsi I
BMJ Open; 2024 Jan; 14(1):e080712. PubMed ID: 38296283
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the SUCCESS Health Literacy App for Australian Adults With Chronic Kidney Disease: Protocol for a Pragmatic Randomized Controlled Trial.
Isautier J; Webster AC; Lambert K; Shepherd HL; McCaffery K; Sud K; Kim J; Liu N; De La Mata N; Raihana S; Kelly PJ; Muscat DM;
JMIR Res Protoc; 2022 Aug; 11(8):e39909. PubMed ID: 36044265
[TBL] [Abstract][Full Text] [Related]
16. Wellbeing intervention for chronic kidney disease (WICKD): a randomised controlled trial study protocol.
Dingwall KM; Nagel T; Hughes JT; Kavanagh DJ; Cass A; Howard K; Sweet M; Brown S; Sajiv C; Majoni SW
BMC Psychol; 2019 Jan; 7(1):2. PubMed ID: 30621791
[TBL] [Abstract][Full Text] [Related]
17. Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trial.
Knowles SR; Ski CF; Langham R; O'Flaherty E; Thompson DR; Rossell SL; Moore G; Hsueh YS; Castle DJ
Trials; 2016 Sep; 17(1):447. PubMed ID: 27612446
[TBL] [Abstract][Full Text] [Related]
18. A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis.
Friedli K; Almond M; Day C; Chilcot J; Gane Mda S; Davenport A; Guirguis A; Fineberg N; Spencer B; Wellsted D; Farrington K
BMC Nephrol; 2015 Oct; 16():172. PubMed ID: 26503099
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
20. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
